Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/164191
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | González Pizarro, Roberto Carlos | - |
dc.contributor.author | Parrotta, Graziella | - |
dc.contributor.author | Vera-García, Rodrigo | - |
dc.contributor.author | Sánchez-López, E. (Elena) | - |
dc.contributor.author | Galindo Camacho, Ruth Milagros | - |
dc.contributor.author | Kjeldsen, Frank | - |
dc.contributor.author | Badía Palacín, Josefa | - |
dc.contributor.author | Baldomà Llavinés, Laura | - |
dc.contributor.author | Espina García, Marta | - |
dc.contributor.author | García López, María Luisa | - |
dc.date.accessioned | 2020-06-04T07:37:28Z | - |
dc.date.available | 2020-11-26T06:10:20Z | - |
dc.date.issued | 2019-11-26 | - |
dc.identifier.issn | 1743-5889 | - |
dc.identifier.uri | https://hdl.handle.net/2445/164191 | - |
dc.description.abstract | Aim: Development of fluorometholone-loaded PEG-PLGA nanoparticles (NPs) functionalized with cellpenetrating peptides for the treatment of ocular inflammatory disorders. Materials & methods: Synthesized polymers and peptides were used for elaboration of functionalized NPs, which were characterized physicochemically. Cytotoxicity and ability to modulate the expression of proinflammatory cytokines were evaluated in vitro using human corneal epithelial cells (HCE-2). NP uptake was assayed in both in vitro and in vivo models. Results: NPs showed physicochemical characteristics suitable for ocular administration without evidence of cytotoxicity. TAT-NPs and G2-NPs were internalized and displayed anti-inflammatory activity in both HCE-2 cells and mouse eye. Conclusion: TAT-NPs and G2-NPs could be considered a novel strategy for the treatment of ocular inflammatory diseases of the anterior and posterior segment. | - |
dc.format.extent | 16 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Future Medicine | - |
dc.relation.isformatof | Versió postprint del document publicat a: https://doi.org/10.2217/nnm-2019-0201 | - |
dc.relation.ispartof | Nanomedicine, 2019, vol. 14, num. 23, p. 3089-3104 | - |
dc.relation.uri | https://doi.org/10.2217/nnm-2019-0201 | - |
dc.rights | (c) Future Medicine, 2019 | - |
dc.source | Articles publicats en revistes (Bioquímica i Fisiologia) | - |
dc.subject.classification | Farmacologia ocular | - |
dc.subject.classification | Agents antiinflamatoris | - |
dc.subject.classification | Sistemes d'alliberament de medicaments | - |
dc.subject.classification | Nanopartícules | - |
dc.subject.classification | Uveïtis | - |
dc.subject.classification | Polímers | - |
dc.subject.classification | Pèptids | - |
dc.subject.other | Ocular pharmacology | - |
dc.subject.other | Antiinflammatory agents | - |
dc.subject.other | Drug delivery systems | - |
dc.subject.other | Nanoparticles | - |
dc.subject.other | Uveitis | - |
dc.subject.other | Polymers | - |
dc.subject.other | Peptides | - |
dc.title | Ocular penetration of fluorometholone-loaded PEG-PLGA nanoparticles functionalized with cell-penetrating peptides | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/acceptedVersion | - |
dc.identifier.idgrec | 694447 | - |
dc.date.updated | 2020-06-04T07:37:29Z | - |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/646603/EU//METALS | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Bioquímica i Fisiologia) Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
694447.pdf | 7.48 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.